FT
AGIO icon

Fiduciary Trust’s Agios Pharmaceuticals AGIO Stock Holding History

Fiduciary Trust’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Buy
8,250
+3
+0% +$91 ﹤0.01% 747
2026
Q1 		$279K Hold
8,247
– – ﹤0.01% 760
2025
Q4 		$224K Buy
8,247
+2,793
+51% +$98K ﹤0.01% 810
2025
Q3 		$219K Buy
+5,454
New +$205K ﹤0.01% 808

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Fiduciary Trust's AGIO Position: Q2 2026 in Review

Fiduciary Trust increased its Agios Pharmaceuticals (AGIO) stake by 0.04% in Q2 2026, buying an estimated $91 and bringing the position to 8,250 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Fiduciary Trust first reported a position in AGIO in Q3 2025 and has held it in 4 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Fiduciary Trust held 8,250 shares of Agios Pharmaceuticals worth $306K as of Q2 2026.
  • Fiduciary Trust bought 3 Agios Pharmaceuticals shares in Q2 2026, an estimated $91.
  • Agios Pharmaceuticals made up ﹤0.01% of Fiduciary Trust's portfolio in Q2 2026, its #747 holding.
  • Fiduciary Trust first reported a position in Agios Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.